Long-term use of mechanical ventilation contributes to the deterioration of human diaphragm muscle

A new study by University of Pennsylvania School of Medicine shows, for the first time in humans, that ventilators combined with diaphragm disuse contributes to muscle atrophy in the diaphragm in as little as eighteen hours. Muscle atrophy in the diaphragm is a major contributor of why patients who have undergone prolonged mechanical ventilation often have difficulty breathing after being removed from the ventilator.

The report, published in the March 27th edition of the New England Journal of Medicine, measured a greater than 50 percent decline in muscle fibers in the diaphragm. In addition, the study measured the proteins that play a key role in the muscle-wasting chemical cascade. By intervening in this pathway, the research suggests, a new pharmacological approach to safely and quickly wean patients off ventilators could be developed.

Sanford Levine, PhD, Professor of Thoracic Surgery and co-director of the Respiratory Muscle Research Laboratory, led a team that conducted 22 biopsies on both deceased and living patients. Fourteen brain-dead organ donors, aged 18 to 58, comprised the case study with each having undergone between 18 and 69 hours of mechanical ventilation. The eight-member control group each received less than three hours.

Levine said both groups were demographically and statistically similar except for the time each had spent on mechanical ventilation. Biopsy results on the other hand were different.

Compared to the control group, the diaphragms of the 14 case study members revealed:

-- 23 percent lower levels of the free-radical fighting antioxidant, glutathione

-- 154 percent more Caspase-3, a calcium-dependant “executioner” enzyme that degrades protein molecules and is responsible for programmed cell deaths

-- Muscle-wasting Atrogin-1 genes at a ratio of 200:1 over MBD4 housekeeper genes that maintain healthy cells

-- MURF-1 nucleotides that attack myofiber proteins at a ratio of 590:1 over housekeeper genes

“From our observations, we conclude that these (biopsy differences) could only be attributed to marked atrophy caused by a combination of complete diaphragm inactivity and mechanical ventilation,” Levine said.

“Disuse atrophy of human diaphragm myofibers could be a major contributor to the weaning problems that occur in some of our patients,” Levine said. “Therefore, we believe fiber atrophy of the magnitude noted in our case diaphragms could have clinical significance.”

Source: University of Pennsylvania

Related stories:

Tiny refrigerator taking shape to cool future computers
Researchers at Purdue University are developing a miniature refrigeration system small enough to fit inside laptops and personal computers, a cooling technology that would boost performance while shrinking the size of computers.
FDA approves NeuRx diaphragm pacing system for use in spinal cord- injured patients
The U.S. Food and Drug Administration (FDA) has approved the NeuRx Diaphragm Pacing System (DPS) for spinal cord-injured patients who are dependent on ventilators for breathing. The light-weight, battery-powered electronic DPS allows patients to breathe and speak more naturally, while eliminating the need for a power source and concern over power outages.
Tiny 'gas-flow' sensor has industrial, environmental applications
Researchers at Purdue University have shown how to create a new class of tiny sensors for applications ranging from environmental protection to pharmaceutical preservation.
Micro-pump is cool idea for future computer chips
Engineers at Purdue University have developed a tiny "micro-pump" cooling device small enough to fit on a computer chip that circulates coolant through channels etched into the chip.
New highly sensitive AFM revolutionizes nano imaging
While a microphone is useful for many things, you probably wouldn't guess that it could help make movies of molecules or measure physical and chemical properties of a material at the nanoscale with just one poke.
Toshiba Develops MEMS Based Manipulation Technology for Injecting Nanoparticles in Cells
Toshiba Corporation today announced the development of manipulation technology for injecting nanoparticles in cells by using subtle vibration generated by a micro electro mechanical system (MEMS)—a fruit of Toshiba's fusion of nanotechnology and biotechnology.
It's The Water: Beijing Olympic Swimmer Provided State-of-Art ProMinent Ozone Technology
(PhysOrg.com) -- As Olympic records are being broken left and right by Michael Phelps, questions have been raised do we have a performance enhancing water issue. Some attribute the gold hanging around Olympiad Phelps is the result of a Superman fabric developed by Speedo. In fact, aside from a truly phenomenal performances by the swimmers, it could be the water. ProMinent, the brainchild of Professor h.c. Viktor Dulger in Heidelberg developed the first electronic solenoid driven dosing pump known as the Ozone Technology system for sanitizing pools in 1971. The system does not rely on chlorine which is viewed as harmful to swimmer's lungs, eyes and may cause skin rashes. ProMinent is a leader world-wide with operations in China, Germany, Hungary and South America.
Lou Gehrig's protein found throughout brain, suggesting effects beyond motor neurons
Two years ago researchers at the University of Pennsylvania School of Medicine discovered that misfolded proteins called TDP-43 accumulated in the motor areas of the brains of patients with amyotropic lateral sclerosis (ALS), or Lou Gehrig's disease. Now, the same group has shown that TDP-43 accumulates throughout the brain, suggesting ALS has broader neurological effects than previously appreciated and treatments need to take into account more than motor neuron areas. Their article appeared in last month's issue of the Archives of Neurology.

News discussion:

Medicine & Health news